A Web-Based Survey on Factors for Unvaccination and Adverse Reactions of SARS-CoV-2 Vaccines in Chinese Patients with Psoriasis
Qiaolin Wang,Chengzhi Lv,Xi Han,Minxue Shen,Yehong Kuang
DOI: https://doi.org/10.2147/JIR.S341429
IF: 4.5
2021-11-27
Journal of Inflammation Research
Abstract:Qiaolin Wang, 1– 3 Chengzhi Lv, 4 Xi Han, 5 Minxue Shen, 1– 3, 6 Yehong Kuang 1– 3 1 Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China; 2 National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Changsha, Hunan, People's Republic of China; 3 Hunan Engineering Research Center of Skin Health and Disease; Hunan Key Laboratory of Skin Cancer and Psoriasis (Xiangya Hospital), Changsha, Hunan, People's Republic of China; 4 Department of Psoriasis, Dalian Dermatosis Hospital, Dalian, Liaoning, People's Republic of China; 5 ULink College Guangzhou, Guangzhou, Guangdong, People's Republic of China; 6 Department of Social Medicine and Health Management, Xiangya School of Public Health, Central South University, Changsha, Hunan, People's Republic of China Correspondence: Minxue Shen Department of Social Medicine and Health Management, Xiangya School of Public Health, Central South University, 87 Xiangya Road, Changsha, Hunan, People's Republic of China Email Yehong Kuang Department of Dermatology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan, People's Republic of China Email Purpose: Vaccination is one of the most important strategy to prevent infections and control epidemics, but it also raises concerns about safety in patients receiving treatments. This study aimed to investigate the rate and factors for unvaccination, as well as adverse reactions and deterioration of disease after SARS-CoV-2 vaccination in psoriatic patients. Methods: A web-based questionnaire survey on SARS-CoV-2 vaccination, adverse reactions, and self-reported change of disease condition after vaccination in patients with psoriasis was conducted. Demographic, clinical, and psychological data were collected. Multivariable logistic regression was used in the estimation of associations. Results: A total of 788 psoriatic patients were investigated, and 68.9% reported SARS-CoV-2 vaccination. Younger age, use of interleukin-17 inhibitors, and symptoms of anxiety were associated with unvaccination. The incidence of overall adverse reactions after vaccination was 30.8%, and no severe adverse reaction was reported. The most common local and systemic adverse reactions were pain at the injection site and fatigue, respectively. Most patients reported no change in psoriasis after vaccination, while 16.6% and 4.4% reported slight and significant deteriorations of the disease, respectively. Nonadherence to treatment, symptoms of anxiety and depression, and perceived stress were associated with self-reported deterioration of psoriasis after vaccination. Conclusion: While a favorable safety profile of SARS-CoV-2 vaccines is observed, receiving biologic treatment is factor for unvaccination in patients with psoriasis. Deterioration of psoriasis reported by a small proportion of patients is partially attributable to mental and behavioral factors. Keywords: COVID-19, SARS-CoV-2, vaccine, unvaccination, psoriasis, safety, adverse reaction Psoriasis is a chronic inflammatory skin disorder linked to genetic, immunologic, metabolic, and environmental factors, 1,2 with an increased risk of infections because of the disease itself or the use of immunosuppressive drugs. 3,4 Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, has spread worldwide, and raised a number of concerns among patients with psoriasis. SARS-CoV-2 vaccination has became one of the most important strategy to prevent the infection and control the pandemic. At the time of data collection, more than 70% Chinese completed the vaccination for SARS-CoV-2, at least five different COVID-19 vaccines, mainly consisting of inactivated and protein subunit vaccine, have been approved for emergency use in China, and a strong willingness to vaccinate in general population was reported by several cross-sectional studies. 5,6 Although psoriasis is not a contraindication for many vaccinations of infectious diseases, the vaccination rate in patients with psoriasis remains low owing to the concerns about the safety of vaccines and unawareness of the risk of infection. 3,7 Although evidence is limited, some case series recently reported psoriasis flare-up linked to SARS-CoV-2 vaccination. 8,9 However, studies systematically investigated adverse reactions after vaccination for SARS-CoV-2 in psoriatic patients are scarce. Real-world data is urgently needed to address public concerns on the side effects of the vaccines. The purpose of the current study is to investigate the rate and factors for SARS-CoV-2 v -Abstract Truncated-
immunology